Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Microvascular and Metabolic Dysregulation in the Pathogenesis of Severe and Cerebral Malaria Investigated Through Host Metabolomics

NCT02451904 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT02451904
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02451904 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Microvascular and Metabolic Dysregulation in the Pathogenesis of Severe and Cerebral Malaria Investigated Through Host Metabolomics
Lead sponsor
University of Oxford
Phase
Observational
Overall status
Completed
Start date
June 30, 2015
Completion date
September 30, 2017
Enrollment
840 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

severe malaria